Hepatitis B testing can show whether you have a current or past HBV infection and whether you have antibodies from a hepatitis B vaccine. Hepatitis B is a viral infection caused by the hepatitis B ...

ERIN: WELCOME BACK. IN THE WAKE OF THE HEPATITIS OUTBREAK IN SOUTH FLORIDA, LOCAL ORGANIZATION FOUND CARE IS OFFERING FREE TESTING TO PATIENTS. HERE TO TELL US MORE, DR. LESLIE DIAZ, EXECUTIVE ...

The closure of the Centers for Disease Control and Prevention (CDC)’s Division of Viral Hepatitis in the wake of the administration’s restructuring of the Department of Health and Human Services ...

Although advances in research have made hepatitis C a treatable condition, many people still face significant barriers to testing and medical care. Two such barriers across the country are a lack of ...

A person with hepatitis C can transmit the infection to a fetus during pregnancy, which may put the baby at risk for complications. If you are planning to become pregnant and have been diagnosed with ...

Innovative approaches to increase testing are needed to achieve the 2030 hepatitis B and hepatitis C elimination targets. Zhang et al., partnering with local community organizations, successfully used ...

Please provide your email address to receive an email when new articles are posted on . An estimated 3.5 million people in the United States are living with the hepatitis C virus, and because the ...

Office worker Kim, 57 years old, was told during every health checkup that he was a hepatitis B carrier. Although the virus ...

Trade-offs in medicine can be harsh, even when clearly necessary. Chemotherapy can save people from cancer, but the side effects can wreak havoc on their bodies for months or years. These trade-offs ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group ...